| Anchored multiplex PCR for targeted next-generation sequencing Z Zheng, M Liebers, B Zhelyazkova, Y Cao, D Panditi, KD Lynch, J Chen, ... Nature medicine 20 (12), 1479-1484, 2014 | 854 | 2014 |
| Open-Label, Multicenter, Phase II Study of Ceritinib in Patients With Non–Small-Cell Lung Cancer Harboring ROS1 Rearrangement SM Lim, HR Kim, JS Lee, KH Lee, YG Lee, YJ Min, EK Cho, SS Lee, ... Journal of clinical oncology 35 (23), 2613-2618, 2017 | 356 | 2017 |
| Fibroblast growth factor receptor 1 gene amplification is associated with poor survival and cigarette smoking dosage in patients with resected squamous cell lung cancer HR Kim, DJ Kim, DR Kang, JG Lee, SM Lim, CY Lee, SY Rha, MK Bae, ... Journal of clinical oncology 31 (6), 731-737, 2013 | 204 | 2013 |
| Unique genetic and survival characteristics of invasive mucinous adenocarcinoma of the lung HS Shim, Z Zheng, M Liebers, YJ Cha, QH Ho, M Onozato, LP Le, ... Journal of Thoracic Oncology 10 (8), 1156-1162, 2015 | 185 | 2015 |
| Distinct clinical features and outcomes in never‐smokers with nonsmall cell lung cancer who harbor EGFR or KRAS mutations or ALK rearrangement HR Kim, HS Shim, JH Chung, YJ Lee, YK Hong, SY Rha, SH Kim, SJ Ha, ... Cancer 118 (3), 729-739, 2012 | 181 | 2012 |
| Clinicopathological and prognostic significance of programmed cell death ligand-1 expression in lung adenocarcinoma and its relationship with p53 status YJ Cha, HR Kim, CY Lee, BC Cho, HS Shim Lung cancer 97, 73-80, 2016 | 150 | 2016 |
| A single-tube multiplexed assay for detecting ALK, ROS1, and RET fusions in lung cancer ME Lira, YL Choi, SM Lim, S Deng, D Huang, M Ozeck, J Han, JY Jeong, ... The Journal of Molecular Diagnostics 16 (2), 229-243, 2014 | 141 | 2014 |
| Histopathologic characteristics of lung adenocarcinomas with epidermal growth factor receptor mutations in the International Association for the Study of Lung Cancer/American … HS Shim, DH Lee, EJ Park, SH Kim Archives of pathology & laboratory medicine 135 (10), 1329-1334, 2011 | 127 | 2011 |
| MET Exon 14 Skipping in Non-Small Cell Lung Cancer RS Heist, HS Shim, S Gingipally, M Mino-Kenudson, L Le, JF Gainor, ... The oncologist 21 (4), 481-486, 2016 | 125 | 2016 |
| LAMC2 enhances the metastatic potential of lung adenocarcinoma YW Moon, G Rao, JJ Kim, HS Shim, KS Park, SS An, B Kim, PS Steeg, ... Cell Death & Differentiation 22 (8), 1341-1352, 2015 | 125 | 2015 |
| Molecular proteomics imaging of tumor interfaces by mass spectrometry S Kang, HS Shim, JS Lee, DS Kim, HY Kim, SH Hong, PS Kim, JH Yoon, ... Journal of proteome research 9 (2), 1157-1164, 2010 | 99 | 2010 |
| The frequency and clinical impact of HER2 alterations in lung adenocarcinoma EK Kim, KA Kim, CY Lee, HS Shim PloS one 12 (2), e0171280, 2017 | 93 | 2017 |
| Repotrectinib exhibits potent antitumor activity in treatment-naïve and solvent-front–mutant ROS1-rearranged non–small cell lung cancer MR Yun, DH Kim, SY Kim, HS Joo, YW Lee, HM Choi, CW Park, SG Heo, ... Clinical Cancer Research 26 (13), 3287-3295, 2020 | 86 | 2020 |
| Screening of ROS1 Rearrangements in Lung Adenocarcinoma by Immunohistochemistry and Comparison with ALK Rearrangements YJ Cha, JS Lee, HR Kim, SM Lim, BC Cho, CY Lee, HS Shim PLoS One 9 (7), e103333, 2014 | 86 | 2014 |
| Biology of invasive mucinous adenocarcinoma of the lung YJ Cha, HS Shim Translational lung cancer research 6 (5), 508, 2017 | 85 | 2017 |
| Autophagy contributes to the chemo-resistance of non-small cell lung cancer in hypoxic conditions JG Lee, JH Shin, HS Shim, CY Lee, DJ Kim, YS Kim, KY Chung Respiratory research 16, 1-9, 2015 | 83 | 2015 |
| Molecular portraits of intratumoral heterogeneity in human ovarian cancer YP Choi, HS Shim, MQ Gao, S Kang, NH Cho Cancer letters 307 (1), 62-71, 2011 | 77 | 2011 |
| Comprehensive analysis of the characteristics and treatment outcomes of patients with non-small cell lung cancer treated with anti-PD-1 therapy in real-world practice BC Ahn, KH Pyo, CF Xin, D Jung, HS Shim, CY Lee, SY Park, HI Yoon, ... Journal of cancer research and clinical oncology 145, 1613-1623, 2019 | 76 | 2019 |
| A case of ALK-rearranged adenocarcinoma with small cell carcinoma-like transformation and resistance to crizotinib YJ Cha, BC Cho, HR Kim, HJ Lee, HS Shim Journal of Thoracic Oncology 11 (5), e55-e58, 2016 | 76 | 2016 |
| Tumor microenvironment dictates regulatory T cell phenotype: upregulated immune checkpoints reinforce suppressive function HR Kim, HJ Park, J Son, JG Lee, KY Chung, NH Cho, HS Shim, S Park, ... Journal for immunotherapy of cancer 7, 1-13, 2019 | 75 | 2019 |
